# Gland Pharma Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63

> Inspection records and compliance data for Gland Pharma Limited in Visakhapatnam, None. Access full analysis and detailed observations.

---

## Details

- Name: Gland Pharma Limited
- FEI Number: 3009056604
- City: Visakhapatnam
- State: None
- Country Name: India
- Address Line 1: Unit I & Unit II, Block C, Phase I, Visakhapatnam Sez; Duvvada
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Gland Pharma Limited - 2026-06-22](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/68a73223-4d49-4e04-a051-2a216208acda) — source: FDA, date: June 22, 2026
- [FDA Inspection 1220251 - Gland Pharma Limited - 2023-07-28](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/f25e54d0-1f98-45a4-8226-c8aa54a8bf11) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2023
- [483 - Gland Pharma Limited - 2019-11-01](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/cb276665-92aa-427d-b63e-73e0bdec767a) — source: FDA, date: November 1, 2019
- [FDA Inspection 1110628 - Gland Pharma Limited - 2019-11-01](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/dcb210ce-c362-4c32-9e94-f2665152f61b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2019
- [FDA Inspection 1061075 - Gland Pharma Limited - 2018-06-15](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/ba25fee5-0b52-447f-8306-e2894b341fe9) — classification: No Action Indicated (NAI), source: FDA, date: June 15, 2018
- [FDA Inspection 1056489 - Gland Pharma Limited - 2018-05-18](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/c53d2600-72cd-4e81-a9e1-34e69012a144) — classification: No Action Indicated (NAI), source: FDA, date: May 18, 2018
- [483 - Gland Pharma Limited - 2017-03-31](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/a230d37b-da9e-4a02-a664-bd1e0e0caa0d) — source: FDA, date: March 31, 2017
- [FDA Inspection 1010051 - Gland Pharma Limited - 2017-03-31](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/f11bc613-6f2c-4144-ad0f-51acc97a860d) — classification: No Action Indicated (NAI), source: FDA, date: March 31, 2017
- [FDA Inspection 936901 - Gland Pharma Limited - 2015-06-30](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/fac87dc6-d40d-4506-80ef-5a93a790d2ce) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2015
- [FDA Inspection 934512 - Gland Pharma Limited - 2015-06-25](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/2053d89c-437a-4b29-b6dc-603fbbb6ccbd) — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2015
- [FDA Inspection 848025 - Gland Pharma Limited - 2013-08-05](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/c0f52470-b0c4-4391-a15d-9af063181159) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 5, 2013

## Related Companies

- [Novartis Pharma Stein AG](https://www.globalkeysolutions.net/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b)
- [Ferring Microbiome Inc.](https://www.globalkeysolutions.net/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85)
- [Eli Lilly & Company](https://www.globalkeysolutions.net/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)
- [Nordmark Arzneimittel GMBH & Co. KG](https://www.globalkeysolutions.net/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b)
- [Cilag AG](https://www.globalkeysolutions.net/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Baxalta Belgium Manufacturing SA](https://www.globalkeysolutions.net/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9)
- [Bristol-Myers Squibb Company](https://www.globalkeysolutions.net/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [AgroChem USA, LLC](https://www.globalkeysolutions.net/companies/agrochem-usa-llc/007b3455-bf3c-4d23-b1e7-0be79ebba21e)
- [Advanced Accelerator Applications (Italy) srl](https://www.globalkeysolutions.net/companies/advanced-accelerator-applications-italy-srl/09ac059c-6735-4082-8674-a88476dbdbc6)
- [Aprecia Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)

## Related Officers

- [Thomas J. Arista](https://www.globalkeysolutions.net/people/thomas-j-arista/37905892-3285-4f3f-b4b5-f963df1e59d3)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.globalkeysolutions.net/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)
- [ Drug Investigator](https://www.globalkeysolutions.net/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783)
- [Investigator](https://www.globalkeysolutions.net/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)